about
Alliance for aging research AD biomarkers work group: structural MRI.A review of β-amyloid neuroimaging in Alzheimer's disease.Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.An expanded role for neuroimaging in the evaluation of memory impairment.Structural interactions within the default mode network identified by Bayesian network analysis in Alzheimer's disease.Biomarkers in Alzheimer's disease.The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging.Ocular manifestations of Alzheimer's disease in animal models.A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.Imaging of glutamate neurotransmitter alterations in Alzheimer's disease.Regional covariance patterns of gray matter alterations in Alzheimer's disease and its replicability evaluation.Association of Cerebral Amyloidosis, Blood Pressure, and Neuronal Injury with Late-Life Onset Depression.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.Histogram-Based Feature Extraction from Individual Gray Matter Similarity-Matrix for Alzheimer's Disease Classification.Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Risk Assessment of Alzheimer's Disease using the Information Diffusion Model from Structural Magnetic Resonance Imaging.Diffusion kurtosis imaging allows the early detection and longitudinal follow-up of amyloid-β-induced pathology.A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
P2860
Q27692607-2D1FC95D-AE33-4CEF-B7C3-2F1E036CBB28Q30870063-7DCAAE9F-E9DD-483F-9069-A1A1707CA0CEQ30870223-F85C4479-7676-4C2C-B522-0C7F3389A7C3Q30871982-42D58D86-FE21-4E13-988B-AED307506E4FQ30996799-A23A5BE3-0D2F-480D-BB20-7D64CF4A7943Q33830698-DF92023A-1D3C-49B9-8987-5E7E356C744BQ34981774-BEEDE304-B43F-4148-83E3-1C210F2F00C1Q35113795-4383336F-FA2C-4160-9964-08E326602604Q35667221-65403226-6569-413B-B0EC-617CD1EDDE2EQ35993835-F9B57364-FA88-41BA-9B09-8B465085D6AEQ36348208-BD4DFF85-9C66-4E12-B8AD-6583BF450D61Q36565888-42D59C20-A356-4326-96FB-1FAC8588D655Q37068138-74610143-4BD8-4E29-AC67-D8EDE07A3DB8Q37334868-B820EDD3-17E8-432E-B4A7-628891DF9A7DQ37627051-CFDA94B2-58E5-47CC-8991-58952FC367F4Q39154725-165DF1B7-2250-494E-9639-2B4150527B5BQ39451605-9DF7B51B-3A9B-417E-A7D9-93B31854A23DQ40101067-DE430467-AF42-4F3E-9F6F-623734B8622AQ44040890-5D7639C4-2742-4EAC-BD2B-41D947BE6AC5Q47839464-45F81E6A-D401-4D2B-A625-71EFC7AB1000Q48229419-50BB212F-1CDF-4444-B056-27C4E857983CQ53396334-D9D88388-FF16-41E0-A2B5-AC63541FF541
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Role of structural MRI in Alzheimer's disease
@ast
Role of structural MRI in Alzheimer's disease
@en
Role of structural MRI in Alzheimer's disease
@nl
type
label
Role of structural MRI in Alzheimer's disease
@ast
Role of structural MRI in Alzheimer's disease
@en
Role of structural MRI in Alzheimer's disease
@nl
prefLabel
Role of structural MRI in Alzheimer's disease
@ast
Role of structural MRI in Alzheimer's disease
@en
Role of structural MRI in Alzheimer's disease
@nl
P2860
P356
P1476
Role of structural MRI in Alzheimer's disease
@en
P2093
Prashanthi Vemuri
P2860
P2888
P356
10.1186/ALZRT47
P407
P577
2010-08-31T00:00:00Z
P5875
P6179
1044837274